Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data.

Tene, Lilac; Karasik, Avraham; Chodick, Gabriel; Pereira, Dora I A; Schou, Henrik; Waechter, Sandra; Göhring, Udo-Michael; Drakesmith, Hal

Tene, Lilac; Karasik, Avraham; Chodick, Gabriel; Pereira, Dora I A; Schou, Henrik; Waechter, Sandra; Göhring, Udo-Michael; Drakesmith, Hal.

Afiliación

Tene L; Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Karasik A; Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Chodick G; Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Pereira DIA; CSL Vifor, Glattbrugg, Switzerland.
Schou H; CSL Vifor, Glattbrugg, Switzerland.
Waechter S; CSL Vifor, Glattbrugg, Switzerland.
Göhring UM; CSL Vifor, Glattbrugg, Switzerland.
Drakesmith H; Medical Research Council Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.

PLoS One ; 18(5): e0285606, 2023.

Article en En | MEDLINE | ID: mdl-37216375

Asunto(s)

COVID-19; Deficiencias de Hierro; Vacunas; Adulto; Embarazo; Humanos; Femenino; Masculino; Vacunas contra la COVID-19/uso terapéutico; COVID-19/prevención & control; Vacuna BNT162; Estudios Retrospectivos; Estudios Longitudinales; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 / Deficiencias de Hierro Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Pregnancy Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google